(Yicai Global) Nov. 9 -- China is further reforming its healthcare by requiring public hospitals to cancel medicine price hikes and improve remuneration for medical staff.
Recently, the General Office of the State Council forwarded relevant opinions on healthcare reforms, requesting a drop in the incorrectly high prices of pharmaceuticals. Liang Wannian, deputy director of the Healthcare Reform Office of the State Council and director of the Department of Healthcare Reform of the National Health and Family Planning Commission, said that all public hospitals must cancel the medicine price hike, comprehensively consider compensation policies defined by local governments and adjust the prices for medical services.
The document says a blacklist will be created for enterprises involved in commercial bribery, in which enterprises dealing in drug production and circulation are involved in bribery -- like kickbacks -- shall be removed from the list of suppliers. Local authorities must rationally define the remuneration level of hospital staff in public hospitals in line with relevant regulations, and remuneration shall be properly raised based on maintaining it at its present level.
The document also requests major principals or one principal from each local party committees and governments to direct local healthcare reform leadership groups.